fashion -WSS

fashion

author：Wikipedia 2025-09-27 22:47:08 - browse：68

Illustration of a person walking across a tightrope, trying to balance. — Adobe

Hospitals are telling government officials it would be illegal to claw back $7.8 billion as part of a remedy that is making hospitals whole over underpaid drug discounts — and they may sue if that plan goes into effect.

The industry is walking a tightrope by trying to maximize the amount of money hospitals can keep. Lobbyists are praising federal officials for agreeing to dole out billions of dollars in future, lump-sum payments, but they are also pressuring Medicare not to offset a penny of those funds.

For several years during the Trump administration, Medicare cut payments for hospitals’ drugs under the federal 340B drug discount program, but the Supreme Court invalidated that policy in 2018. In July, Medicare proposed a solution: Hospitals would get $9 billion to cover what they are owed under the 340B program, but to offset those costs, the government would recoup $7.8 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： ARCH Venture Partners tops STAT's 2023 biotech VC rankings

focus

entertainment

WSS

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Readout Newsletter: What happened with Sarepta's Duchenne data

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Wikipedia

fashion

Wikipedia

Bright Health sells Medicare Advantage business to Molina

In early work, researchers turn to CRISPR to treat Alzheimer's

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Malaria cases in Florida and Texas: Here’s what you need to know

Testing for cancer recurrence creates a new limbo for patients

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

A public scorecard can help hold safety

After affirmative action ruling, medical educators look to 'holistic review'

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

hotspot

FDA has safety concerns on CRISPR

Key House panel plots a new health care package

Cassava reveals details — and problems — with Alzheimer's study

Readout Newsletter: XBI biotech index, Akero Therapeutics

The pink breast cancer awareness ribbon needs a redesign

Google and Epic fight stronger regulation of AI in health care

focus

leisure time

entertainment

entertainment